This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: National Institute of Advanced Industrial Science and Technology, Shisei Datum Co., Ltd.. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2012
Title: Minoru Tokiwa: Innovator in Vascular Measurement Technology
Introduction
Minoru Tokiwa is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of medical technology, particularly in the measurement of vascular properties. His innovative approach has led to the development of a unique apparatus that enhances the understanding of vascular health.
Latest Patents
Tokiwa holds a patent for an "Apparatus for measuring vascular viscoelasticity index." This invention is designed to provide a noninvasive, simple, and cost-effective method for measuring the vascular viscoelasticity index. The apparatus utilizes a specific formula to calculate the index, which is crucial for assessing vascular health.
Career Highlights
Throughout his career, Tokiwa has worked with prominent organizations, including Shisei Datum Co., Ltd. and the National Institute of Advanced Industrial Science and Technology. His experience in these institutions has allowed him to refine his inventions and contribute to advancements in medical technology.
Collaborations
Tokiwa has collaborated with esteemed colleagues such as Yukiyoshi Saito and Toshikazu Yokokawa. These partnerships have fostered innovation and have been instrumental in the development of his patented technologies.
Conclusion
Minoru Tokiwa's work in the field of vascular measurement technology exemplifies the impact of innovative thinking in healthcare. His contributions continue to influence the way vascular health is assessed and monitored.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile